Caris+ vs HemeOncBuddy Utilisation & Stats
The Caris+ App provides convenient access to manage and review Caris profiling cases. View current and past patient results whenever and wherever you are.
• View and search current and past cases
• Receive real-time case notifications
• Track testing progress
• Approve orders
• View interactive results and select clinical trial matches
• Request Caris Molecular Tumor Board review
• Share patient educational information
About Caris Life Sciences
Caris Life Sciences® is a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine through quality and innovation. The company’s suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make more precise and personalized treatment decisions.
Caris is also advancing precision medicine with Caris Artificial Intelligence, combining its market leading service offering, Caris Molecular Intelligence® with its proprietary artificial intelligence analytics engine, DEAN™. This information, coupled with mature clinical outcomes on thousands of patients, provides unmatched molecular solutions for patients, physicians, payers and biopharmaceutical organizations.
- Apple App Store
- Gratuit
- Médical
Classement dans le store
- -
Research in Hematology and Oncology has seen a remarkable growth with a significant amount of treatment advancements in recent years. Keeping up with recent literature has become more challenging. In the HemeOncBuddy app you can find the most important and practice-changing clinical trials in Hematology and Oncology.
The goal of this app is to make clinical trial information easily available for quick reference. The trial summaries are organized in a unique simplified way to provide all the pertinent information on one page. Every trial summary includes background information with inclusion criteria for the population of interest. The exclusion criteria are included if the editor deems them to be important or different from other trials. Every unique summary has information on the primary endpoints, median follow up, and the outcomes on primary endpoints.
More information on our website: https://www.hemeoncbuddy.com
- Apple App Store
- Gratuit
- Médical
Classement dans le store
- -
Caris+ VS. 
HemeOncBuddyjanvier 9, 2025